Cyxone AB
CYXO | ST
Overview
Corporate Details
- ISIN(s):
- SE0007815428 (+2 more)
- LEI:
- 54930034OH16ROAY4K87
- Country:
- Sweden
- Address:
- Hyllie Boulevard 34, 215 32 Malmö
- Website:
- https://www.cyxone.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Cyxone AB develops disease-modifying therapies for autoimmune diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Cyxone AB filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for Cyxone AB
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Cyxone AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-06-28 | Carl Magnus Högerkorp | Other | Buy | 64,950 | 40,788.60 SEK |
| 2023-06-27 | Carl Magnus Högerkorp | Other | Buy | 6,050 | 3,690.50 SEK |
| 2023-03-03 | Carl Magnus Högerkorp | Other | Buy | 100,010 | 51,005.10 SEK |
| 2023-03-02 | Carl Magnus Högerkorp | Other | Buy | 10,873 | 5,653.96 SEK |
| 2021-07-15 | Bert Junno | Other | Other | 1,788,732 | 7,763,096.88 SEK |
| 2021-07-15 | Bert Junno | Other | Other | 1,788,732 | N/A |
| 2021-07-14 | Bert Junno | Other | Other | 1,788,786 | 7,790,163.03 SEK |
| 2021-07-14 | Bert Junno | Other | Other | 1,788,786 | N/A |
| 2021-07-12 | Mikeoo Holding AB | Other | Other | 1,788,732 | 7,441,125.12 SEK |
| 2021-07-12 | Mikael Lindstam | Other | Other | 1,788,732 | N/A |
Peer Companies
Company
Country
Ticker
View
Developing pharmaceuticals for urological oncology using its proprietary GuaDex technology platform.
Sweden
DEX
Sweden
DEX
Develops sustainable tech for EV drivetrains and next-gen energy storage materials.
United Kingdom
DGI
United Kingdom
DGI
Developing next-gen potency drugs for erectile dysfunction and premature ejaculation.
Sweden
DICOTBT
Sweden
DICOTBT
A deep-tech factory building Physical AI ventures for mobility, logistics, and automation.
Italy
E9IA
Italy
E9IA
Spain
EEP
CRO offering preclinical drug profiling, screening & pharmacology testing for pharma/biotech.
France
ALECR
France
ALECR
Germany
EVT
Develops myeloid cell-targeting immunotherapies for solid and hematological cancers.
Finland
FARN
Finland
FARN